Pro-Dex, Inc. – NASDAQ:PDEX
Pro-Dex stock price today
$43.92
-5.37
-10.91%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 13 hours
Pro-Dex stock price monthly change
+177.43%
month
Pro-Dex stock price quarterly change
+177.43%
quarter
Pro-Dex stock price yearly change
+185.80%
year
Pro-Dex key metrics
Market Cap | 154.13M |
Enterprise value | 72.42M |
P/E | 16.3 |
EV/Sales | 1.63 |
EV/EBITDA | 12.43 |
Price/Sales | 1.31 |
Price/Book | 2.38 |
PEG ratio | -1.73 |
EPS | 2.02 |
Revenue | 50.62M |
EBITDA | 7.94M |
Income | 7.48M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 8.64% |
Oper. margin | 9.7% |
Gross margin | 26.85% |
EBIT margin | 9.7% |
EBITDA margin | 15.7% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePro-Dex stock price history
Pro-Dex stock forecast
Pro-Dex financial statements
| Jun 2022 | 12.61M | 1.40M | 11.14% |
|---|---|---|---|
| Mar 2023 | 13.07M | 1.61M | 12.36% |
| Jun 2023 | 10.63M | 3.80M | 35.77% |
| Mar 2024 | 14.29M | 655K | 4.58% |
| 2023-05-03 | 0.26 | 0.12 |
|---|
| Dec 2022 | 47579000 | 23.10M | 48.56% |
|---|---|---|---|
| Mar 2023 | 46975000 | 21.13M | 44.99% |
| Jun 2023 | 51823000 | 20.23M | 39.04% |
| Mar 2024 | 50548000 | 19.61M | 38.79% |
| Jun 2022 | -5.27M | 401K | 966K |
|---|---|---|---|
| Mar 2023 | 2.33M | -135K | -497K |
| Jun 2023 | 627K | -152K | 373K |
| Mar 2024 | 4.07M | -117K | -2.02M |
Pro-Dex alternative data
| Aug 2023 | 134 |
|---|---|
| Sep 2023 | 134 |
| Oct 2023 | 134 |
| Nov 2023 | 145 |
| Dec 2023 | 145 |
| Jan 2024 | 145 |
| Feb 2024 | 145 |
| Mar 2024 | 145 |
| Apr 2024 | 145 |
| May 2024 | 145 |
| Jun 2024 | 145 |
| Jul 2024 | 145 |
Pro-Dex other data
100.00%
+86.49%
of PDEX is owned by hedge funds
12
-10
250.37K
-248.69K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2024 | 0 | 2585 |
| Nov 2024 | 0 | 1000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | DOMINGO ANGELITA REBAMONTAN director | Common Stock | 4,250 | $27.5 | $116,875 | ||
Option | DOMINGO ANGELITA REBAMONTAN director | Stock Options | 4,250 | $27.3 | $116,025 | ||
Sale | CHARLTON ALISHA officer: Chief Fi.. | Common Stock | 1,000 | $40.02 | $40,020 | ||
Sale | DOMINGO ANGELITA REBAMONTAN director | Common Stock | 2,585 | $18.3 | $47,295 | ||
Option | HOVDA DAVID director | Director Stock Option (Right to Buy) | 1,500 | N/A | N/A | ||
Option | HOVDA DAVID director | Common Stock | 1,500 | $2.14 | $3,210 | ||
Option | VAN KIRK RICHARD LEE JR director, officer.. | Employee Stock Option (Right to Buy) | 5,000 | $1.73 | $8,650 | ||
Option | VAN KIRK RICHARD LEE JR director, officer.. | Common Stock | 5,000 | $1.73 | $8,650 | ||
Purchase | PHILP KATRINA MARIE KRAMER director | Common Stock | 3,900 | $14.98 | $58,422 | ||
Purchase | FARRELL WILLIAM JAMES III director | Common Stock | 2,000 | $20.62 | $41,240 |
| Patent |
|---|
Application Filling date: 9 Jul 2021 Issue date: 30 Jun 2022 |
Application Filling date: 13 Jul 2021 Issue date: 30 Dec 2021 |
Application Filling date: 25 May 2021 Issue date: 9 Dec 2021 |
Grant Filling date: 19 Aug 2019 Issue date: 17 Aug 2021 |
Grant Filling date: 21 Aug 2019 Issue date: 3 Aug 2021 |
Grant Filling date: 24 Jun 2019 Issue date: 27 Jul 2021 |
Application Filling date: 6 Feb 2020 Issue date: 9 Jul 2020 |
Application Filling date: 21 Aug 2019 Issue date: 5 Mar 2020 |
Application Filling date: 19 Aug 2019 Issue date: 20 Feb 2020 |
Application Filling date: 24 Jun 2019 Issue date: 6 Feb 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2015 14 Nov 2014 | Q1 2015 Earnings Call Transcript |
| Q4 2014 18 Sep 2014 | Q4 2014 Earnings Call Transcript |
| Q3 2014 13 May 2014 | Q3 2014 Earnings Call Transcript |
| Q2 2014 7 Feb 2014 | Q2 2014 Earnings Call Transcript |
-
What's the price of Pro-Dex stock today?
One share of Pro-Dex stock can currently be purchased for approximately $43.92.
-
When is Pro-Dex's next earnings date?
Unfortunately, Pro-Dex's (PDEX) next earnings date is currently unknown.
-
Does Pro-Dex pay dividends?
No, Pro-Dex does not pay dividends.
-
How much money does Pro-Dex make?
Pro-Dex has a market capitalization of 154.13M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16.83% to 53.84M US dollars. Pro-Dex earned 2.13M US dollars in net income (profit) last year or $0.12 on an earnings per share basis.
-
What is Pro-Dex's stock symbol?
Pro-Dex, Inc. is traded on the NASDAQ under the ticker symbol "PDEX".
-
What is Pro-Dex's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Pro-Dex?
Shares of Pro-Dex can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Pro-Dex's key executives?
Pro-Dex's management team includes the following people:
- Mr. Richard Lee Van Kirk Jr. Chief Executive Officer, Pres, Chief Operating Officer & Director(age: 64, pay: $416,150)
- Ms. Alisha K. Charlton Chief Financial Officer & Corporation Sec.(age: 55, pay: $242,530)
-
How many employees does Pro-Dex have?
As Jul 2024, Pro-Dex employs 145 workers.
-
When Pro-Dex went public?
Pro-Dex, Inc. is publicly traded company for more then 39 years since IPO on 7 Aug 1986.
-
What is Pro-Dex's official website?
The official website for Pro-Dex is pro-dex.com.
-
Where are Pro-Dex's headquarters?
Pro-Dex is headquartered at 2361 McGaw Avenue, Irvine, CA.
-
How can i contact Pro-Dex?
Pro-Dex's mailing address is 2361 McGaw Avenue, Irvine, CA and company can be reached via phone at +94 97693200.
Pro-Dex company profile:
Pro-Dex, Inc.
pro-dex.comExchange:
NASDAQ
Full time employees:
146
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
2361 McGaw Avenue
Irvine, CA 92614
Irvine, CA 92614
CIK: 0000788920
ISIN: US74265M2052
CUSIP: 74265M205
